• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 M.R.I. HARD BASE IMPLANTABLE PORT, HICKMAN SINGLE-LUMEN, 6.6F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 M.R.I. HARD BASE IMPLANTABLE PORT, HICKMAN SINGLE-LUMEN, 6.6F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Model Number 0604580
Medical Device Problem Codes Fracture (1260); Material Separation (1562); Dent in Material (2526); Migration (4003)
Health Effect - Clinical Code Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Date of Event 07/14/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
As the lot number for the device was provided, a review of the device history records is currently being performed.The return of the sample is pending.The investigation of the reported event is currently underway.(expiration date: 12/2024).
 
Event or Problem Description
It was reported that approximately ten months post port placement, the catheter allegedly fractured and separated.It was further reported that the catheter allegedly migrated into the pulmonary artery.Reportedly the catheter was removed.The current status of the patient is unknown.
 
Additional Manufacturer Narrative
H10: manufacturing review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: one bard mri hard-base implantable port attached to a catheter was returned for evaluation.Gross, microscopic visual, tactile evaluation and functional testing were performed.In addition to the returned physical sample, two medical images and one medical record were provided for review.During sample evaluation, a complete circumferential break was noted on the distal end of the catheter segment which was elliptical in shape.Further, the edges of the complete circumferential break on the distal end of the attached catheter were noted to be uneven and the surface was noted to be granular.However, the medical record review states, approximately ten months post port implantation, a computed tomography (ct) was performed.It revealed that, distal segment material was rupture, being located in the right and left main branches of the pulmonary artery with a total length of around 13 cm.Subsequently, a hemodynamic procedure was performed to remove the device from pulmonary artery.The image review also confirms the same.Therefore, the investigation is confirmed for the reported catheter fracture, migration and material separation and identified dent issues.The characteristics of the break are indicative of pinch-off.A definitive root cause could not be determined based upon the available information.Labeling review: a review of product labeling documentation (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.Instruction for use states: "pinch-off prevention: catheters placed percutaneously or through a cutdown, into the subclavian vein, should be inserted at the junction of the outer and middle thirds of the clavicle, lateral to the thoracic outlet.The catheter should not be inserted into the subclavian vein medially, because such placement can lead to compression of the catheter between the first rib and the clavicle, which can cause damage and even sever the catheter.A radiographic confirmation of catheter placement should be made to ensure that the catheter is not being pinched by the first rib and clavicle.1,2" h10: d4 (expiration date: 12/2024), g3, h6 (device).H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported that approximately ten months post port placement, the catheter allegedly fractured and separated.It was further reported that the catheter allegedly migrated into the pulmonary artery.Reportedly, the catheter was removed.The current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
M.R.I. HARD BASE IMPLANTABLE PORT, HICKMAN SINGLE-LUMEN, 6.6F
Common Device Name
PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key15741943
Report Number3006260740-2022-04321
Device Sequence Number5838202
Product Code LJT
UDI-Device Identifier00801741025877
UDI-Public(01)00801741025877
Combination Product (Y/N)N
Initial Reporter CountryBR
PMA/510(K) Number
K873213
Number of Events Summarized1
Summary Report (Y/N)N
Device Explanted Year2022
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,User Facility,Company Representative,Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number0604580
Device Catalogue Number0604580
Device Lot NumberREEW2068
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 10/11/2022
Supplement Date Received by Manufacturer01/04/2023
Initial Report FDA Received Date11/07/2022
Supplement Report FDA Received Date01/10/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured10/15/2020
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age53 YR
Patient SexFemale
-
-